ResearcherJiangxi Provincial Cancer HospitalActive in the last 2 years

Jun Zou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-6863-1831; OpenAlex author ID A5101301482. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

miR-630 as a therapeutic target in pancreatic cancer stem cells: modulation of the PRKCI-Hedgehog signaling axis. Co-author DOI 10.1186/s13062-024-00539-1 ↗
LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 via targeting FOXP3. Co-author DOI 10.1111/jcmm.16930 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Daiwen Chen · 1 shared paper, 2024 · strength 0.26
- Paper miR-630 as a therapeutic target in pancreatic cancer stem cells: modulation of the PRKCI-Hedgehog signaling axis. DOI 10.1186/s13062-024-00539-1 ↗
Xuanzeng Pei · 1 shared paper, 2021 · strength 0.17
- Paper LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 vi… DOI 10.1111/jcmm.16930 ↗
Shuai Chen · 1 shared paper, 2021 · strength 0.17
- Paper LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 vi… DOI 10.1111/jcmm.16930 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.